LWAY Lifeway Foods Inc.

Lifeway Foods, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

Lifeway Foods, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

MORTON GROVE, Ill., March 18, 2021 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, March 25, 2021 before market hours.

A pre-recorded conference call and webcast with Lifeway CEO Julie Smolyansky discussing these results with additional comments and details will be available on March 25, 2021 at approximately 9:00 a.m. ET. The webcast will be available over the Internet through the “Investor Relations” section of the Company’s website at /webinars-reports/. An audio replay will be available through April 8, 2021. North American listeners may dial 844-512-2921 and international listeners may dial 412-317-6671. The passcode is 11144015.

About Lifeway Foods, Inc.

Lifeway Foods, Inc., which has been recognized as one of Forbes’ Best Small Companies, is America’s leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces cupped kefir and cheese, frozen kefir, specialty cheeses, probiotic supplements and a ProBugs line for kids. Lifeway’s tart and tangy fermented dairy and non-dairy products are now sold across the United States, Mexico, Ireland and the United Kingdom. Learn how Lifeway is good for more than just you at .

Contact:

Lifeway Foods, Inc.

Phone: 847-967-1010

Email:



EN
18/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifeway Foods Inc.

Lifeway Foods Inc: 3 directors

A director at Lifeway Foods Inc sold 10,000 shares at 17.190USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Lifeway’s Independent Directors Support CEO Julie Smolyansky and Lifew...

Lifeway’s Independent Directors Support CEO Julie Smolyansky and Lifeway 2.0 Strategy MORTON GROVE, Ill., March 01, 2022 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today issued a response to the recent 13D filing. The independent Directors of the Board issued the following response: “Lifeway’s independent Directors fully supports CEO Julie Smolyansky and her continued execution of the Lifeway 2.0 strategy. Julie has consistently delivered growth for...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch